RESULTS	In the subgroup of 81 patients with limb onset of the disease , 28 patients ( 74 % ) in the acetylcysteine group and 22 ( 51 % ) in the placebo group survived 12 months ( hazard ratio , 0.50 ; 95 % confidence interval , 0.24 to 1.04 ; P = .06 ) .\